TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+5.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$483M
AUM Growth
+$483M
(+16%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
8.3%
Top 10 Holdings %
Top 10 Hldgs %
61.19%
Holding
32
New
12
Increased
7
Reduced
8
Closed
4
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$39M |
| 2 |
Bristol-Myers Squibb
BMY
|
$20.1M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$19.9M |
| 4 |
Idexx Laboratories
IDXX
|
$18.6M |
| 5 |
UnitedHealth
UNH
|
$14.2M |
Top Sells
| 1 |
Pfizer
PFE
|
$50.2M |
| 2 |
Vaxcyte
PCVX
|
$31.1M |
| 3 |
United Therapeutics
UTHR
|
$19.7M |
| 4 |
Natera
NTRA
|
$18.2M |
| 5 |
Stevanato
STVN
|
$16.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
LivaNova
LIVN
$3.09B
| $4.62M | 0.96% |
+99,700
| New | +$4.62M |
|
27
Praxis Precision Medicines
PRAX
$980M
| $2.87M | 0.59% |
+37,269
| New | +$2.87M |
|
28
Femasys
FEMY
$12M
| $33.7K | 0.01% |
30,606
| – | – |
|
29
Insmed
INSM
$30.3B
| – | – |
-143,920
| Closed | -$10.5M |
|
|
30
Vaxcyte
PCVX
$4.17B
| – | – |
-271,922
| Closed | -$31.1M |
|
|
31
Pfizer
PFE
$141B
| – | – |
-1,732,935
| Closed | -$50.2M |
|
|
32
United Therapeutics
UTHR
$17.7B
| – | – |
-54,926
| Closed | -$19.7M |
|